Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 11 - Therapieende

- 20/11/17 - 1 formulario, 7 itemgroups, 53 items, 1 idioma

Itemgroups: Administrative Documentation, Physical Examination, Laboratory Data, Diagnostic procedures, Results, Progress, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 11 - Therapieende (Woche 28) Toxizitäten / Unerwünschte Ereignisse / Hospitalisierungen werden im 1. Follow up dokumentiert. Das 1. Follow-up findet 3 Monate nach der letzten Chemotherapie statt.

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 8

- 20/11/17 - 1 formulario, 10 itemgroups, 71 items, 1 idioma

Itemgroups: Administrative Documentation, Adverse Event, Physical Examination, Laboratory Data, Disease Progression, Diagnostic procedures, Postoperative Chemotherapy, Capecitabine, Life quality, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 8 - Chemotherapie-Zyklus 4 (Woche 19)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 10

- 20/11/17 - 1 formulario, 9 itemgroups, 65 items, 1 idioma

Itemgroups: Administrative Documentation, Physical Examination, Laboratory Data, Disease Progression, Additive Chemotherapy, Capecitabine, Life quality, Adverse Event, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 10 - Chemotherapie-Zyklus 6 (Woche 25)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 9

- 20/11/17 - 1 formulario, 7 itemgroups, 62 items, 1 idioma

Itemgroups: Administrative Documentation, Physical Examination, Laboratory Data, Additive Chemotherapy, Capecitabine, Adverse Event, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 8 - Chemotherapie-Zyklus 5 (Woche 22)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 7 - Entlassung

- 19/11/17 - 1 formulario, 8 itemgroups, 58 items, 1 idioma

Itemgroups: Administrative Documentation, Hospital stay information, Physical Examination, Laboratory Data, Non-surgical Complications, Surgical Complications, Adverse Event, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 7 – Entlassung

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 4

- 16/11/17 - 1 formulario, 8 itemgroups, 57 items, 1 idioma

Itemgroups: Administrative Documentation, Physical Examination, Laboratory Data, Diagnostic procedures, Results, Disease Progression, Adverse Event, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 4 – Ende Chemotherapie-Zyklus 3 (Woche 9)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 3

- 16/11/17 - 1 formulario, 8 itemgroups, 64 items, 1 idioma

Itemgroups: Administrative Documentation, Physical Examination, Laboratory Data, Disease Progression, Preoperative Chemotherapy, Capecitabine, Adverse Event, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 3 – Chemotherapie-Zyklus 3 (Woche 6)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 2

- 16/11/17 - 1 formulario, 8 itemgroups, 64 items, 1 idioma

Itemgroups: Administrative Documentation, Physical Examination, Laboratory Data, Disease Progression, Preoperative Chemotherapy, Capecitabine, Adverse Event, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 2 – Chemotherapie-Zyklus 2 (Woche 3)

Palabras clave

Tabla de contenido

Modelos de datos seleccionados